Distinct subtypes of endometriosis identified based on stromal-immune microenvironment and gene expression: implications for hormone therapy

BackgroundEndometriosis (EMs) is a chronic inflammatory condition that is highly heterogeneous. Current clinical staging fails to accurately predict drug responses and prognosis. In this study, we aimed to reveal the heterogeneity of ectopic lesions and investigate the possible underlying mechanisms...

Full description

Bibliographic Details
Main Authors: Yuning Wang, Yun Chen, Yinping Xiao, Jingyao Ruan, Qi Tian, Qi Cheng, Kaikai Chang, Xiaofang Yi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1133672/full
_version_ 1797797720392466432
author Yuning Wang
Yun Chen
Yun Chen
Yinping Xiao
Jingyao Ruan
Qi Tian
Qi Cheng
Kaikai Chang
Kaikai Chang
Xiaofang Yi
Xiaofang Yi
author_facet Yuning Wang
Yun Chen
Yun Chen
Yinping Xiao
Jingyao Ruan
Qi Tian
Qi Cheng
Kaikai Chang
Kaikai Chang
Xiaofang Yi
Xiaofang Yi
author_sort Yuning Wang
collection DOAJ
description BackgroundEndometriosis (EMs) is a chronic inflammatory condition that is highly heterogeneous. Current clinical staging fails to accurately predict drug responses and prognosis. In this study, we aimed to reveal the heterogeneity of ectopic lesions and investigate the possible underlying mechanisms using transcriptomic data and clinical information.MethodsThe EMs microarray dataset GSE141549 was obtained from the Gene Expression Omnibus database. Unsupervised hierarchical clustering was performed to identify EMs subtypes, which was followed by the functional enrichment analysis and estimation of immune infiltrates. Subtype-associated gene signatures were identified and further validated in other independent datasets, including GSE25628, E-MTAB-694, and GSE23339. Additionally, tissue microarrays (TMAs) were generated from premenopausal patients with EMs to investigate the potential clinical implications of the two identified subtypes.ResultsThe unsupervised clustering analysis revealed that ectopic EMs lesions can be classified into two distinct subtypes: stroma-enriched (S1) and immune-enriched (S2). The functional analysis revealed that S1 correlated with fibroblast activation and extracellular matrix remodeling in the ectopic milieu, whereas S2 was characterized by the upregulation of immune pathways and a higher positive correlation with the immunotherapy response. Moreover, we identified a subtype signature composed of FHL1 and SORBS1, and constructed a subtype diagnostic model. Based on the cohort data from the TMAs, we found that S2 was strongly associated with the failure of/intolerance to hormone therapy.ConclusionsThis study identified two distinct subtypes that are varyingly associated with hormone resistance, stroma-immunity, and molecular features, thereby highlighting the importance of this stromal-immune heterogeneity in identifying EMs subtypes and providing novel insights into future personalized hormone-free therapy in EMs.
first_indexed 2024-03-13T03:52:38Z
format Article
id doaj.art-340a1d6baab2485d8c3a339d1cf98403
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-13T03:52:38Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-340a1d6baab2485d8c3a339d1cf984032023-06-22T09:25:53ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-06-011410.3389/fimmu.2023.11336721133672Distinct subtypes of endometriosis identified based on stromal-immune microenvironment and gene expression: implications for hormone therapyYuning Wang0Yun Chen1Yun Chen2Yinping Xiao3Jingyao Ruan4Qi Tian5Qi Cheng6Kaikai Chang7Kaikai Chang8Xiaofang Yi9Xiaofang Yi10Department of Gynecology, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai, ChinaDepartment of Gynecology, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai, ChinaKey Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai, ChinaDepartment of Gynecology, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai, ChinaDepartment of Gynecology, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai, ChinaDepartment of Gynecology, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai, ChinaDepartment of Gynecology, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai, ChinaDepartment of Gynecology, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai, ChinaKey Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai, ChinaDepartment of Gynecology, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai, ChinaKey Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University, Shanghai, ChinaBackgroundEndometriosis (EMs) is a chronic inflammatory condition that is highly heterogeneous. Current clinical staging fails to accurately predict drug responses and prognosis. In this study, we aimed to reveal the heterogeneity of ectopic lesions and investigate the possible underlying mechanisms using transcriptomic data and clinical information.MethodsThe EMs microarray dataset GSE141549 was obtained from the Gene Expression Omnibus database. Unsupervised hierarchical clustering was performed to identify EMs subtypes, which was followed by the functional enrichment analysis and estimation of immune infiltrates. Subtype-associated gene signatures were identified and further validated in other independent datasets, including GSE25628, E-MTAB-694, and GSE23339. Additionally, tissue microarrays (TMAs) were generated from premenopausal patients with EMs to investigate the potential clinical implications of the two identified subtypes.ResultsThe unsupervised clustering analysis revealed that ectopic EMs lesions can be classified into two distinct subtypes: stroma-enriched (S1) and immune-enriched (S2). The functional analysis revealed that S1 correlated with fibroblast activation and extracellular matrix remodeling in the ectopic milieu, whereas S2 was characterized by the upregulation of immune pathways and a higher positive correlation with the immunotherapy response. Moreover, we identified a subtype signature composed of FHL1 and SORBS1, and constructed a subtype diagnostic model. Based on the cohort data from the TMAs, we found that S2 was strongly associated with the failure of/intolerance to hormone therapy.ConclusionsThis study identified two distinct subtypes that are varyingly associated with hormone resistance, stroma-immunity, and molecular features, thereby highlighting the importance of this stromal-immune heterogeneity in identifying EMs subtypes and providing novel insights into future personalized hormone-free therapy in EMs.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1133672/fullendometriosisheterogeneitysubtypeimmune infiltrationfibroblast activationunsupervised hierarchical clustering
spellingShingle Yuning Wang
Yun Chen
Yun Chen
Yinping Xiao
Jingyao Ruan
Qi Tian
Qi Cheng
Kaikai Chang
Kaikai Chang
Xiaofang Yi
Xiaofang Yi
Distinct subtypes of endometriosis identified based on stromal-immune microenvironment and gene expression: implications for hormone therapy
Frontiers in Immunology
endometriosis
heterogeneity
subtype
immune infiltration
fibroblast activation
unsupervised hierarchical clustering
title Distinct subtypes of endometriosis identified based on stromal-immune microenvironment and gene expression: implications for hormone therapy
title_full Distinct subtypes of endometriosis identified based on stromal-immune microenvironment and gene expression: implications for hormone therapy
title_fullStr Distinct subtypes of endometriosis identified based on stromal-immune microenvironment and gene expression: implications for hormone therapy
title_full_unstemmed Distinct subtypes of endometriosis identified based on stromal-immune microenvironment and gene expression: implications for hormone therapy
title_short Distinct subtypes of endometriosis identified based on stromal-immune microenvironment and gene expression: implications for hormone therapy
title_sort distinct subtypes of endometriosis identified based on stromal immune microenvironment and gene expression implications for hormone therapy
topic endometriosis
heterogeneity
subtype
immune infiltration
fibroblast activation
unsupervised hierarchical clustering
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1133672/full
work_keys_str_mv AT yuningwang distinctsubtypesofendometriosisidentifiedbasedonstromalimmunemicroenvironmentandgeneexpressionimplicationsforhormonetherapy
AT yunchen distinctsubtypesofendometriosisidentifiedbasedonstromalimmunemicroenvironmentandgeneexpressionimplicationsforhormonetherapy
AT yunchen distinctsubtypesofendometriosisidentifiedbasedonstromalimmunemicroenvironmentandgeneexpressionimplicationsforhormonetherapy
AT yinpingxiao distinctsubtypesofendometriosisidentifiedbasedonstromalimmunemicroenvironmentandgeneexpressionimplicationsforhormonetherapy
AT jingyaoruan distinctsubtypesofendometriosisidentifiedbasedonstromalimmunemicroenvironmentandgeneexpressionimplicationsforhormonetherapy
AT qitian distinctsubtypesofendometriosisidentifiedbasedonstromalimmunemicroenvironmentandgeneexpressionimplicationsforhormonetherapy
AT qicheng distinctsubtypesofendometriosisidentifiedbasedonstromalimmunemicroenvironmentandgeneexpressionimplicationsforhormonetherapy
AT kaikaichang distinctsubtypesofendometriosisidentifiedbasedonstromalimmunemicroenvironmentandgeneexpressionimplicationsforhormonetherapy
AT kaikaichang distinctsubtypesofendometriosisidentifiedbasedonstromalimmunemicroenvironmentandgeneexpressionimplicationsforhormonetherapy
AT xiaofangyi distinctsubtypesofendometriosisidentifiedbasedonstromalimmunemicroenvironmentandgeneexpressionimplicationsforhormonetherapy
AT xiaofangyi distinctsubtypesofendometriosisidentifiedbasedonstromalimmunemicroenvironmentandgeneexpressionimplicationsforhormonetherapy